Hungta Chen

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

Jadwiga A. Wedzicha, Marc Decramer, Joachim H. Ficker et al. · The Lancet Respiratory Medicine · 2013 · 538 citations

Asthma, Advanced Lung Disease, Parallel-group Study +4

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

Claus Vogelmeier, Eric Bateman, John Pallante et al. · The Lancet Respiratory Medicine · 2012 · 312 citations

Twice-daily Salmeterol–fluticasone, Pulmonary Care, Allergy +8

Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)

Mikhail Kosiborod, Marília Brito Gomes, Antonio Nicolucci et al. · Cardiovascular Diabetology · 2018 · 251 citations · Full text

Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes

Chantal Mathieu, Aurelian-Emil Ranetti, Danshi Li et al. · Diabetes Care · 2015 · 142 citations

Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study

Navdeep Tangri, Markus P. Schneider, Jean Blaise J. Virgitti et al. · BMJ Open · 2023 · 112 citations · Full text